<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="7758" whole_study_id="5544" phs="000168" v="2" p="2" createDate="2012-03-15T13:21:12-05:00" completedByGPADate="2014-05-06T09:32:03-05:00" modDate="2019-07-19T13:30:59-05:00" maxParentChildStudyModDate="2019-07-19T13:30:59-05:00" handle="LOAD_610K_CIDR_NCRAD" num_participants="4700"><StudyInfo accession="phs000168.v2.p2" parentAccession="phs000168.v2.p2"><BioProject id="PRJNA75485" entrez_id="75485" type="bp_admin_access"/><BioProject id="PRJNA75487" entrez_id="75487" type="bp_data_submission"/><StudyNameEntrez>CIDR_NIA Late Onset Alzheimer's Disease:Genome-Wide Association Study</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><Funding>U24 AG026395-02</Funding></StudyInfo><Authority><ICs><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false"/><IC id="16" name="NIA" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="MAYEUX" aid="2" auth="eRA" login="MAYEUX" fname="Richard" lname="Mayeux" email="rpm2@columbia.edu"><Role>PI</Role><Organization>COLUMBIA UNIVERSITY HEALTH SCIENCES</Organization></Person><Person nedid="0010063767" aid="1" auth="cit" login="rossiw" fname="Winifred" mname="Kathleen" lname="Rossi" email="winnie_rossi@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Kelley " lname="Faber" email="kelfaber@iu.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010063767" aid="1" auth="cit" login="rossiw" fname="Winifred" mname="Kathleen" lname="Rossi" email="winnie_rossi@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement>INSTRUCTIONS:  This study has not provided a suggested acknowledgement statement. However, Approved Users are expected to acknowledge the Submitting Investigator(s) who submitted data from the original study to an NIH-designated data repository, the primary funding organization that supported the Submitting Investigator(s), and the NIH-designated data repository (e.g., dbGaP).  The acknowledgment statement should include the dbGaP accession number to the specific version of the dataset(s) analyzed.</acknowledgement_statement><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="1383" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

Subject consented to Alzheimer disease research conducted by non-profit and for-profit (pharmaceutical and biotechnology companies) organizations. Consented to genetic research of any human diseases conducted by non-profit and for-profit (pharmaceutical and biotechnology companies) organizations.</Use-Restriction></ConsentGroup><ConsentGroup uid="1384" CGType="cg_class_DS" title="Disease-Specific (Alzheimer Disease, NPU)" name="DS-ALZ-NPU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Alzheimer Disease.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup><ConsentGroup uid="1385" CGType="cg_class_DS" title="Disease-Specific (Alzheimer Disease)" name="DS-ALZ" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Alzheimer Disease.

</Use-Restriction></ConsentGroup><ConsentGroup uid="1472" CGType="cg_class_other" title="Non Profit Use" name="NPU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research and genetic research of any human disease at non-profit organizations only.</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="1383"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="5544" whole_study_id="5544" phs="000168" v="1" p="1" createDate="2009-04-15T14:39:31-05:00" modDate="2020-09-01T09:19:38-05:00" maxParentChildStudyModDate="2020-09-01T09:19:38-05:00" handle="LOAD_610K_NCRAD" num_participants="4700"><StudyInfo accession="phs000168.v1.p1" parentAccession="phs000168.v1.p1"><BioProject id="PRJNA75485" entrez_id="75485" type="bp_admin_access"/><BioProject id="PRJNA75487" entrez_id="75487" type="bp_data_submission"/><StudyNameEntrez>CIDR_NIA Late Onset Alzheimer's Disease:Genome-Wide Association Study</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><Description>
&lt;p&gt;Alzheimer disease is the most common neurodegenerative disorder of the elderly affecting an estimated five million Americans. Genetic   factors contribute to the risk for disease with heritability estimates ranging from 57% to 79%. More than a decade ago, the &amp;#949;4   variant of APOE was identified and remains the most consistently replicated genetic variant influencing the risk of late onset   Alzheimer disease. A segregation analysis suggests there may be four additional genes influencing the age-at-onset of Alzheimer   disease. In 2007 there were 968 association studies in 398 candidate genes reported, but none replicated consistently. There are   many reasons for the lack of consistency, but one important reason for the lack of progress is the paucity of a sufficient number   of well characterized families and patients available to the entire scientific community. The extensive effort and expense required   to ascertain such a population has been addressed by the NIA-LOAD Family Study. Its goal is to identify and recruit families with two   or more siblings with the late-onset form of Alzheimer&amp;#39;s disease and a cohort of unrelated, non-demented controls similar in age   and ethnic background, and to make the samples, the clinical and genotyping data and preliminary analyses available to qualified   investigators world-wide. Genotyping by the Center for Inherited Disease Research (CIDR) was performed using the Illumina Infinium II   assay protocol with hybridization to Illumina Human 610Quadv1_B Beadchips.  This genotyping represents the largest collection of   families ever assembled with Alzheimer&amp;#39;s disease combining the NIA-LOAD Genetics Initiative Multiplex Family Study, the National   Cell Repository for Alzheimer&amp;#39;s Disease (NCRAD) with additional controls from the University of Kentucky. These genotyping results   will serve as a focal point for future research that will identify all of the remaining genetic variants in Alzheimer&amp;#39;s disease.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;&lt;b&gt;NIA-LOAD Genetics Initiative Multiplex Family Study&lt;/b&gt;&lt;br/&gt;     In 2002, the administration of the National Institute of Aging (NIA) created the NIA-Genetics Initiative for Late-Onset Alzheimer&amp;#39;s    Disease.  As part of that program the NIA-Late Onset Alzheimer&amp;#39;s Disease (NIA-LOAD) Family Study was developed for the specific    recruitment of individuals from families with multiple family members affected by late onset Alzheimer&amp;#39;s disease.  Initial recruitment    was supported through administrative supplements to 18 institutions federally funded as Alzheimer&amp;#39;s Disease Centers. A    consortium of 10 sites continues to recruit new families and conduct longitudinal assessments on families and controls.   &lt;/p&gt;   &lt;p&gt;&lt;b&gt;National Cell Repository for Alzheimer&amp;#39;s Disease&lt;/b&gt;&lt;br/&gt;   The &lt;b&gt;N&lt;/b&gt;ational &lt;b&gt;C&lt;/b&gt;ell &lt;b&gt;R&lt;/b&gt;epository for &lt;b&gt;A&lt;/b&gt;lzheimer&amp;#39;s &lt;b&gt;D&lt;/b&gt;isease (NCRAD) was established to collect   and maintain information and biological specimens on large numbers of genetically informative, phenotypically   well-characterized, families having multiple individuals affected with Alzheimer Disease (AD). The goal of NCRAD has been to   ensure that researchers have access to the types of families and samples needed to address critical research questions.   &lt;/p&gt;
 </StudyHistory><Attributions><Header title="Principal Investigators"><AttrName>Richard Mayeux, MD, MSc</AttrName><Institution>Columbia University, New York, NY, USA</Institution></Header><Header title="Principal Investigators"><AttrName>Tatiana Foroud, PhD</AttrName><Institution>National Cell Repository for Alzheimer's Disease and Indiana University, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Joseph H. Lee, PhD</AttrName><Institution>Columbia University, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Ellen M. Wijsman, PhD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Robert Green, MD, MPH</AttrName><Institution>Boston University, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Neil Kowall, MD</AttrName><Institution>Boston University, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Lindsay Farrer, PhD</AttrName><Institution>Boston University, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Donald E. Schmechel, MD</AttrName><Institution>Duke University, Durham NC, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Deborah Blacker, MD, ScD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>John Growdon, MD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Bradley T. Hyman, MD, PhD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Rudolph E. Tanzi, PhD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Bradley Boeve, MD</AttrName><Institution>Mayo Clinic Rochester, MN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Neill Graff-Radford, MD</AttrName><Institution>Mayo Clinic, Jacksonville, FL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Margaret Pericak-Vance, PhD</AttrName><Institution>Miami Institute for Human Genomics, University of Miami, Miami, FL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jeremy M. Silverman, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Michal Schnaider Beeri, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Mary Sano, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Nancy Johnson, PhD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Marsel Mesulam, MD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Sandra Weintraub, PhD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Eileen Bigio, MD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jeffrey Kaye, MD</AttrName><Institution>Layton Center for Aging and Alzheimer's Disease, Oregon Health &amp; Science University, Portland, OR, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Patricia Kramer, PhD</AttrName><Institution>Layton Center for Aging and Alzheimer's Disease, Oregon Health &amp; Science University, Portland, OR, USA</Institution></Header><Header title="Co-Investigators"><AttrName>David A. Bennett, MD</AttrName><Institution>Rush University Medical Center, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Lindy E. Harrell, MD, PhD</AttrName><Institution>University of Alabama at Birmingham, AL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>George Bartzokis, MD</AttrName><Institution>David Geffen School of Medicine, University of California, Los Angeles, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>William Markesbery, MD</AttrName><Institution>University of Kentucky, Lexington, KY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Charles Smith, MD</AttrName><Institution>University of Kentucky, Lexington, KY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>John Q. Trojanowski, MD, PhD</AttrName><Institution>University of Pennsylvania, Philadelphia, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Vivianna Van Deerlin, MD, PhD</AttrName><Institution>University of Pennsylvania, Philadelphia, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Steven T. DeKosky, MD</AttrName><Institution>University of Pittsburgh, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Robert Sweet, MD</AttrName><Institution>University of Pittsburgh, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>I. Helena Chui, MD</AttrName><Institution>University of Southern California, Downey, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Arousiak Varpetian, MD</AttrName><Institution>University of Southern California, Downey, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Ramon Diaz-Arrastia, MD, PhD</AttrName><Institution>University of Texas Southwestern Medical Center at Dallas, TX, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Roger Rosenberg, MD</AttrName><Institution>University of Texas Southwestern Medical Center at Dallas, TX, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Thomas Bird, MD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Murray Raskind, MD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Gerard D. Schellenberg, PhD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Alison Goate, DPhil</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Co-Investigators"><AttrName>John Morris, MD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Marcelle Morrison-Bogorad, PhD</AttrName><Institution>National Institute on Aging, Bethesda, MD, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Marilyn Miller, PhD</AttrName><Institution>National Institute on Aging, Bethesda, MD, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Creighton H. Phelps, PhD</AttrName><Institution>National Institute on Aging, Bethesda, MD, USA</Institution></Header><Header title="Funding Source for Genotyping"><AttrName>HHSN268200782096C. "NIH contract High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jeffrey Kaye, MD</AttrName><Institution>Layton Center for Aging and Alzheimer's Disease, Oregon Health and Science University, Portland, OR, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Patricia Kramer, PhD</AttrName><Institution>Layton Center for Aging and Alzheimer's Disease, Oregon Health and Science University, Portland, OR, USA</Institution></Header></Attributions><StudyURLs><Url name="The Alzheimer's Disease Genetics Initiative" url="http://www.niageneticsinitiative.org"/><Url name="The National Cell Repository for Alzheimer's Disease (NCRAD)" url="http://www.ncrad.org"/></StudyURLs><Publications><Publication><Pubmed pmid="19001172"/></Publication></Publications><Funding>U24 AG026395-02</Funding></StudyInfo><Authority><ICs><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false"/><IC id="16" name="NIA" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="MAYEUX" aid="2" auth="eRA" login="MAYEUX" fname="Richard" lname="Mayeux" email="rpm2@columbia.edu"><Role>PI</Role><Organization>COLUMBIA UNIVERSITY HEALTH SCIENCES</Organization></Person><Person nedid="0010063767" aid="1" auth="cit" login="rossiw" fname="Winifred" mname="Kathleen" lname="Rossi" email="winnie_rossi@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010063767" aid="1" auth="cit" login="rossiw" fname="Winifred" mname="Kathleen" lname="Rossi" email="winnie_rossi@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=5717&amp;file=get&amp;page=file" filename="Mayeux 610K LOAD study DUC_Final.doc" md5="03bd70c0626e659e055228b0df5aad60" size="69632" modDate="2009-09-18T15:03:22-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=16536&amp;file=get&amp;page=file" filename="Mayeux 610K LOAD study DUC_Final.doc.pdf" md5="fe9341e054fff0ef2c15bc4a371ad807" size="109334" modDate="2015-08-31T15:56:54-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="91" CGType="cg_class_other" title="Non Profit Use" name="NPU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research and genetic research of any human disease at non-profit organizations only.</Use-Restriction></ConsentGroup><ConsentGroup uid="92" CGType="cg_class_other" title="Alzheimer Disease Only " name="ALZ" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research only at non-profit and for-profit (pharmaceutical and biotechnology companies) organizations.</Use-Restriction></ConsentGroup><ConsentGroup uid="93" CGType="cg_class_other" title="Alzheimer Disease and Non-Profit Use Only " name="ALZ_NPU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research only at non-profit organizations.</Use-Restriction></ConsentGroup><ConsentGroup uid="94" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research conducted by non-profit and for-profit (pharmaceutical and biotechnology companies) organizations. Consented to genetic research of any human diseases conducted by non-profit and for-profit (pharmaceutical and biotechnology companies) organizations.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>